UAB "Biotechnologijų centras" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 13,000 |
| 13,000 |
| 6,252 |
| 6,016 |
| 6,016 |
| 92.18 |
| 46.28 |
| -332,856 |
| 290,157 |
| 2,270 |
| -44,969 |
| -5.42 |
| -0.87 |
| 98.84 |
| 12,849 |
| 92.18 |
| 11,983 |
| 2024 |
|---|
| 38,914 |
| 38,914 |
| 18,296 |
| 15,818 |
| 15,818 |
| 66.67 |
| 40.65 |
| -317,038 |
| 289,202 |
| 1,369 |
| -29,205 |
| -1.57 |
| -0.91 |
| 68.99 |
| 26,845 |
| 66.67 |
| 25,944 |
| 2025 |
|---|
| 4,850 |
| 4,850 |
| 288 |
| -288 |
| -288 |
| 78.19 |
| -5.94 |
| -317,326 |
| 294,215 |
| 468 |
| -23,579 |
| -12.49 |
| -0.93 |
| 96.76 |
| 4,693 |
| 78.19 |
| 3,792 |
| 2025 |
|---|
| 4,850 |
| 4,850 |
| 288 |
| -288 |
| -288 |
| 78.19 |
| -5.94 |
| -317,326 |
| 294,215 |
| 468 |
| -23,579 |
| -12.49 |
| -0.93 |
| 96.76 |
| 4,693 |
| 78.19 |
| 3,792 |
Turnover (€)
2025
Turnover (€)
4,850 €-88 % *
Sales per employee (€)
4,850 €-88 % *
Profit before tax (€)
288 €-98 % *
Net Profit (€)
-288 €-102 % *
Profit per employee (€)
-288 €-102 % *
Total profitability (%)
78.19 %17.28 % *
Net profitability (%)
-5.94 %-114.61 % *
Equity (€)
-317,326 €0 % *
Amounts Payable And Liabilities (€)
294,215 €2 % *
Non-current Assets (€)
468 €-66 % *
CurrentAssets (€)
-23,579 €19 % *
Working capital requirement
-12.49 -695.54 % *
Debt-to-equity ratio
-0.93 -2.20 % *
EBITDA margin (%)
96.76 %40.25 % *
EBITDA (€)
4,693 €-83 % *
EBIT margin (%)
78.19 %17.28 % *
EBIT (€)
3,792 €-85 % *
